P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 20 March 2019 | 7:29 pm

Novo Nordisk files oral semaglutide for US regulatory approval of glycaemic control, as well as for CV risk reduction for oral semaglutide and Ozempic®

Bagsværd, Denmark, 20 March 2019 - Novo Nordisk today announced the submission of two New Drug Applications (NDAs) to the US Food and Drug Administration (FDA) for oral more ...

Published 20 March 2019 | 2:49 pm

Press Release Archives

NCCN Announces Six Quality Improvement Projects in Gastric Cancer Care Approved for Collaboration with Lilly Oncology more ...

Published 20 March 2019 | 12:24 pm

Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics

Pfizer and Vivet to collaborate on development of potential breakthrough therapy for Wilson disease Pfizer acquires 15% ownership stake in Vivet more ...

Published 20 March 2019 | 1:47 am

Novo Nordisk settles US patent litigation case on Victoza® (liraglutide) with Teva

Bagsværd, Denmark, 18 March 2019 - Novo Nordisk today announced that a settlement between Novo Nordisk and Teva Pharmaceuticals USA, Inc. (Teva) has been reached on more ...

Published 19 March 2019 | 11:47 pm

Merck KGaA, Darmstadt, Germany, and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer

Darmstadt, Germany and New York, US, March 19, 2019 - Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the US and more ...

Published 19 March 2019 | 6:59 pm

Data from GARNET study indicates robust activity of dostarlimab in patients with advanced or recurrent endometrial cancer

GARNET is the single largest study to date of an anti-PD-1 monotherapy in women with advanced or recurrent MSI-H and MSS endometrial cancer more ...

Published 19 March 2019 | 3:27 pm

Visualizing immuno-oncology research

Learn how Novartis researchers are working to outsmart tumors. more ...

Published 19 March 2019 | 3:04 pm

Pfizer Invites Public to View and Listen to Webcast of April 30 Conference Call with Analysts

Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, April 30, 2019. The more ...

Published 19 March 2019 | 7:01 am

Investor Update

FDA approves Roche's Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer Tecentriq in combination with more ...

Published 19 March 2019 | 6:20 am

Baxter and bioMérieux Announce Collaboration to Improve Identification and Treatment of Acute Kidney Injury

Baxter International Inc. (NYSE: BAX), a global leader in acute care, and bioMérieux, a world leader in the field of in vitro diagnostics, announced an agreement to develop more ...

Pharma Documentation Ring:
26 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
Next Annual General Meeting, Vienna, September 25 – 28, 2018

Next Annual General Meeting, Vienna, September 25 – 28, 2018